RGS1 and neoplasm: Although the exact mechanism of action remains to be discovered, it is certain that RGS1 promotes tumour cell proliferation, migration and invasion and is associated with poor prognostic survival in diffuse large B-cell lymphoma and multiple myeloma [38, 120] (Figs. 4 and 5, Table 1).